Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUDT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
INSC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCGR3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR142 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF33A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFRSF10D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
BCORP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAZ4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100653049 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NKAIN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP157 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR37L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CKAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on